EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab.

Biologics · 2009 · PMC2726075 · PMID 19707410

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

87 Progression free survival and disease control rate (DCR) were statistically significantly better in FISH (+) patients, and there was a nonsignificant trend toward higher objective response rate (ORR) as compared to FISH (−) patients in both arms.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.